Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lung Neoplasms 6Hematologic Neoplasms 5Breast Neoplasms 5Colorectal Neoplasms 4Anatomic Stage I Breast Cancer AJCC v8 4Prostatic Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Breast Carcinoma In Situ 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Neoplasms 2Multiple Myeloma 2Lymphoma 2Head and Neck Carcinoma 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2COVID-19 2Uveal Melanoma 1Urologic Neoplasms 1Urologic Diseases 1Smoking 1Resectable Colorectal Carcinoma 1Renal Insufficiency, Chronic 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Oligometastatic Malignant Solid Neoplasm 1Leukemia, Myeloid, Acute 1Hypogonadism 1

Interventions

Cyclophosphamide 35fludarabine 18Methotrexate 17fludarabine phosphate 16Dexamethasone 16Vincristine 15blinatumomab 14Cytarabine 14Melphalan 12Etoposide 12Tacrolimus 11pegaspargase 10Whole-Body Irradiation 10Mercaptopurine 9Calcium Dobesilate 9Busulfan 9merphos 8Mycophenolic Acid 8Dasatinib 8Asparaginase 8Thiotepa 7Prednisone 7Peripheral Blood Stem Cell Transplantation 7Leucovorin 7Granulocyte Colony-Stimulating Factor 7Doxorubicin 7prednylidene 6ponatinib 6calaspargase pegol 6Stem Cell Transplantation 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Practice Guidelines as Topic × Clear all
NCT05428176 2026-05-27

A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors

City of Hope Medical Center

Phase NA Active not recruiting
342 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡